VIRA/Kenneth Eade/HPCS/Kevin Buckman
Interesting the way they moved Buckman's company over to HPCS.
VIRA involved Kenneth Eade - did it not?
======
pinky HPCS description:
Business Description
The Company specializes in advances in Supplements for Health, and Anti-Aging with a special interest in Preventative Medicine. The Company was formed to distribute nutraceuticals formulas developed over thirty years of research by Dr. Kevin Buckman. Dr. Buckman has created more than a dozen fucoidan-based formulas which are intended to address the needs of individuals suffering from DDS (Degenerative Disease Syndrome), which includes such maladies as gastrointestinal disorders, auto-immune diseases, asthma, Alzeimer's, dementia, diabetes, arthritis, cancer, and heart disease.
The Company is focused on delivering nutraceutical formulas that can help diabetes and heart disease, along with new diagnostics for early detection of a predisposition to these disease states. Recognition of diabetes and vascular-cardiac disease is a very important part of this program since over one half of men and women have significant cardiovascular disease and millions of Americans have Diabetes and don?t know it.
=====
ABOUT WELLNESSBUILDER: www.wellnessbuilder.com
The Company specializes in advances in Supplements for Health, and Anti-Aging with a special interest in Preventative Medicine. The Company was formed to distribute nutraceutical formulas developed over thirty years of research by world renowned team of UCLA scientists. Wellnessbuilder scientists have created more than a dozen fucoidan-based formulas which are intended to address the needs of individuals suffering from DDS (Degenerative Disease Syndrome), which includes such maladies as gastrointestinal disorders, auto-immune diseases, asthma, Alzeimer's, dementia, diabetes, arthritis, cancer, and heart disease.
========
VIRATECH ANNOUNCES DR. KEVIN BUCKMAN AS ITS NEW CEO
(SE) Chris Ryan November 07, 2012
Font size: + -
STOCKTON, CALIFORNIA/November 8, 2012 NEWSWIRE -- Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today that Kevin Buckman MD has taken the position of CEO for the Company. As Founder of Viratech,...
STOCKTON, CALIFORNIA/November 8, 2012 NEWSWIRE -- Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today that Kevin Buckman MD has taken the position of CEO for the Company.
As Founder of Viratech, Dr. Buckman understands the goals and opportunities for the Company. He developed many of the technologies that are key components of Viratech as well as holds a vast medical experience. He has had CEO and business experience that compliments his goals to move the Company forward.
=======
